BARCLAYS PLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$109
+91.2%
45,542
+40.7%
0.00%
Q2 2023$57
-82.0%
32,368
-68.4%
0.00%
Q1 2023$316
+2.6%
102,545
+76.5%
0.00%
Q4 2022$308
-99.7%
58,109
+84.7%
0.00%
Q3 2022$111,000
+46.1%
31,459
+6.3%
0.00%
Q2 2022$76,000
-50.0%
29,601
-13.2%
0.00%
Q1 2022$152,00034,0990.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$10,454,0001.67%
Boxer Capital, LLC 1,251,055$12,536,0000.44%
Pentwater Capital Management LP 4,967,227$49,772,0000.41%
KNOTT DAVID M 29,566$296,0000.10%
Perceptive Advisors 1,575,490$15,786,0000.10%
Virtus ETF Advisers LLC 24,287$243,0000.10%
Advisory Services Network, LLC 256,772$2,573,0000.08%
J. Goldman & Co LP 202,501$2,029,0000.08%
Ikarian Capital, LLC 85,837$861,0000.07%
Regent Investment Management LLC 25,000$251,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders